is a topic covered in the Johns Hopkins ABX Guide
To view the entire topic, please sign in or purchase a subscription.
Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:
-- The first section of this topic is shown below --
In combination with peg-interferon and ribavirin, telaprevir indicated for the treatment of HCV (genotype1) patients with compensated liver disease, including cirrhosis, who are treatment-naïve OR who have been previously treated with interferon-based regimen, but had no response, partial response, or relapsed (no longer available in U.S.)
-- To view the remaining sections of this topic, please sign in or purchase a subscription --
Last updated: February 9, 2018
Smith, Janessa, and Paul A Pham. "Telaprevir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540606/all/Telaprevir.
Smith J, Pham PA. Telaprevir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540606/all/Telaprevir. Accessed September 15, 2019.
Smith, J., & Pham, P. A. (2018). Telaprevir. In Johns Hopkins ABX Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540606/all/Telaprevir
Smith J, Pham PA. Telaprevir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2019 September 15]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540606/all/Telaprevir.
TY - ELEC
T1 - Telaprevir
ID - 540606
A1 - Smith,Janessa,Pharm.D. BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2018/02/09/
BT - Johns Hopkins ABX Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540606/all/Telaprevir
PB - The Johns Hopkins University
DB - Johns Hopkins Guide
DP - Unbound Medicine